{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:30:23Z","timestamp":1777545023741,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03260-3","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:11:35Z","timestamp":1773058295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient-derived spheroid culture: A promising in vitro model for drug screening in retinoblastoma"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4699-1477","authenticated-orcid":false,"given":"Rathinavel","family":"Sethu Nagarajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sekaran","family":"Balaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhakrishnan","family":"Shanthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowri Priya","family":"Chidambaranathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramprasad","family":"Obula Giridhara Gopalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayyasamy","family":"Vanniarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"3260_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/jamaoncol.2019.6716","volume":"6","author":"Global Retinoblastoma Study Group","year":"2020","unstructured":"Global Retinoblastoma Study Group. Global retinoblastoma presentation and analysis by National income level. JAMA Oncol. 2020;6:685\u201395. https:\/\/doi.org\/10.1001\/jamaoncol.2019.6716.","journal-title":"JAMA Oncol"},{"key":"3260_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41433-018-0244-7","volume":"33","author":"M Jain","year":"2019","unstructured":"Jain M, Rojanaporn D, Chawla B, Sundar G, Gopal L, Khetan V. Retinoblastoma in Asia. Eye. 2019;33:87\u201396. https:\/\/doi.org\/10.1038\/s41433-018-0244-7.","journal-title":"Eye"},{"key":"3260_CR3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/s12887-023-04347-w","volume":"23","author":"MO Atima","year":"2023","unstructured":"Atima MO, Idakwo U, Komolafe O, Eisuke S, Shintaro N, Balogun EO, et al. Presentation pattern and survival rate of retinoblastoma following chemotherapy: a prospective study. BMC Pediatr. 2023;23:538. https:\/\/doi.org\/10.1186\/s12887-023-04347-w.","journal-title":"BMC Pediatr"},{"key":"3260_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/B978-0-443-12049-7.00051-8","volume-title":"Clin cases ocul oncol first ed [Internet]","author":"T Kritfuangfoo","year":"2025","unstructured":"Kritfuangfoo T, Chokchaitanasin R, Tsutsumi WD, Rojanaporn D. Chapter 51 - Retinoblastoma\u2014Metastatic. In: Ramasubramanian A, Shields CL, editors. Clin cases ocul oncol first ed [Internet]. New Delhi: Elsevier; 2025. pp. 241\u20135. [cited 2024 Dec 27]. https:\/\/doi.org\/10.1016\/B978-0-443-12049-7.00051-8."},{"key":"3260_CR5","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.3390\/cimb46060317","volume":"46","author":"X Ma","year":"2024","unstructured":"Ma X, Li X, Sun Q, Luan F, Feng J. Molecular biological research on the pathogenic mechanism of retinoblastoma. Curr Issues Mol Biol Multidisciplinary Digit Publishing Inst. 2024;46:5307\u201321. https:\/\/doi.org\/10.3390\/cimb46060317.","journal-title":"Curr Issues Mol Biol Multidisciplinary Digit Publishing Inst"},{"key":"3260_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s11033-025-10475-6","volume":"52","author":"R Sethu Nagarajan","year":"2025","unstructured":"Sethu Nagarajan R, Kim U, Shanthi R, Vanniarajan A. Investigation of GD2 synthase as a potential marker for retinoblastoma poor prognosis. Mol Biol Rep. 2025;52:372. https:\/\/doi.org\/10.1007\/s11033-025-10475-6.","journal-title":"Mol Biol Rep"},{"key":"3260_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12032-024-02391-9","volume":"41","author":"S Balaji","year":"2024","unstructured":"Balaji S, Rao A, Saraswathi KK, Sethu Nagarajan R, Santhi R, Kim U, et al. Focused cancer pathway analysis revealed unique therapeutic targets in retinoblastoma. Med Oncol Northwood Lond Engl. 2024;41:168. https:\/\/doi.org\/10.1007\/s12032-024-02391-9.","journal-title":"Med Oncol Northwood Lond Engl"},{"key":"3260_CR8","doi-asserted-by":"publisher","first-page":"109447","DOI":"10.1016\/j.exer.2023.109447","volume":"230","author":"IL Sinenko","year":"2023","unstructured":"Sinenko IL, Turnell-Ritson RC, Munier FL, Dyson PJ. The predictive capacity of in vitro preclinical models to evaluate drugs for the treatment of retinoblastoma. Exp Eye Res. 2023;230:109447. https:\/\/doi.org\/10.1016\/j.exer.2023.109447.","journal-title":"Exp Eye Res"},{"key":"3260_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nbt.2786","volume":"32","author":"M Hay","year":"2014","unstructured":"Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32:40\u201351. https:\/\/doi.org\/10.1038\/nbt.2786.","journal-title":"Nat Biotechnol"},{"key":"3260_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jacbts.2019.10.008","volume":"4","author":"GA Van Norman","year":"2019","unstructured":"Van Norman GA. Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach? JACC Basic Transl Sci. 2019;4:845\u201354. https:\/\/doi.org\/10.1016\/j.jacbts.2019.10.008.","journal-title":"JACC Basic Transl Sci"},{"key":"3260_CR11","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1111\/cas.15878","volume":"114","author":"IL Sinenko","year":"2023","unstructured":"Sinenko IL, Kuttler F, Simeonov V, Moulin A, Aouad P, Stathopoulos C, et al. Translational screening platform to evaluate chemotherapy in combination with focal therapy for retinoblastoma. Cancer Sci. 2023;114:3728\u201339. https:\/\/doi.org\/10.1111\/cas.15878.","journal-title":"Cancer Sci"},{"key":"3260_CR12","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s13346-023-01327-6","volume":"13","author":"TS Biju","year":"2023","unstructured":"Biju TS, Priya VV, Francis AP. Role of three-dimensional cell culture in therapeutics and diagnostics: an updated review. Drug Deliv Transl Res. 2023;13:2239\u201353. https:\/\/doi.org\/10.1007\/s13346-023-01327-6.","journal-title":"Drug Deliv Transl Res"},{"key":"3260_CR13","doi-asserted-by":"publisher","first-page":"100116","DOI":"10.1016\/j.onano.2022.100116","volume":"9","author":"SR Alves","year":"2023","unstructured":"Alves SR, Calori IR, Bi H, Tedesco AC. Characterization of glioblastoma spheroid models for drug screening and phototherapy assays. OpenNano. 2023;9:100116. https:\/\/doi.org\/10.1016\/j.onano.2022.100116.","journal-title":"OpenNano"},{"key":"3260_CR14","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41419-024-07285-2","volume":"15","author":"E Alefeld","year":"2024","unstructured":"Alefeld E, Haase A, Van Meenen D, Budeus B, Dr\u00e4ger O, Miroschnikov N, et al. In vitro model of retinoblastoma derived tumor and stromal cells for tumor microenvironment (TME) studies. Cell Death Dis Nat Publishing Group. 2024;15:905. https:\/\/doi.org\/10.1038\/s41419-024-07285-2.","journal-title":"Cell Death Dis Nat Publishing Group"},{"key":"3260_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.yexcr.2019.03.034","volume":"379","author":"Z Tang","year":"2019","unstructured":"Tang Z, Ma H, Mao Y, Ai S, Zhang P, Nie C, et al. Identification of stemness in primary retinoblastoma cells by analysis of stem-cell phenotypes and tumorigenicity with culture and xenograft models. Exp Cell Res. 2019;379:110\u20138. https:\/\/doi.org\/10.1016\/j.yexcr.2019.03.034.","journal-title":"Exp Cell Res"},{"key":"3260_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/jhg.2015.62","volume":"60","author":"K Thirumalairaj","year":"2015","unstructured":"Thirumalairaj K, Abraham A, Devarajan B, Gaikwad N, Kim U, Muthukkaruppan V, et al. A Stepwise strategy for rapid and cost-effective RB1 screening in Indian retinoblastoma patients. J Hum Genet Nat Publishing Group. 2015;60:547\u201352. https:\/\/doi.org\/10.1038\/jhg.2015.62.","journal-title":"J Hum Genet Nat Publishing Group"},{"key":"3260_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13048-017-0365-9","volume":"10","author":"FC Kischkel","year":"2017","unstructured":"Kischkel FC, Meyer C, Eich J, Nassir M, Mentze M, Braicu I, et al. Prediction of clinical response to drugs in ovarian cancer using the chemotherapy resistance test (CTR-test). J Ovarian Res. 2017;10:72. https:\/\/doi.org\/10.1186\/s13048-017-0365-9.","journal-title":"J Ovarian Res"},{"key":"3260_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2174\/1568009620666200504112711","volume":"20","author":"S Balaji","year":"2020","unstructured":"Balaji S, Santhi R, Kim U, Muthukkaruppan V, Priya CG, Vanniarajan A. Cancer stem cells with overexpression of neuronal markers enhance chemoresistance and invasion in retinoblastoma. Curr Cancer Drug Targets. 2020;20:710\u20139. https:\/\/doi.org\/10.2174\/1568009620666200504112711.","journal-title":"Curr Cancer Drug Targets"},{"key":"3260_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1586\/17469899.2013.826053","volume":"8","author":"B Appukuttan","year":"2013","unstructured":"Appukuttan B, Biswas,Jyotirmay. Enucleation in retinoblastoma: pros and cons. Expert Rev Ophthalmol Taylor Francis. 2013;8:351\u20133. https:\/\/doi.org\/10.1586\/17469899.2013.826053.","journal-title":"Expert Rev Ophthalmol Taylor Francis"},{"key":"3260_CR20","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1136\/bjophthalmol-2019-315572","volume":"104","author":"CL Shields","year":"2020","unstructured":"Shields CL, Bas Z, Tadepalli S, Dalvin LA, Rao R, Schwendeman R, et al. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre. Br J Ophthalmol. 2020;104:1548. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-315572.","journal-title":"Br J Ophthalmol"},{"key":"3260_CR21","doi-asserted-by":"publisher","unstructured":"Nag A, Khetan V. Retinoblastoma \u2013 A comprehensive review, update and recent advances. Indian J Ophthalmol 2024;72(6):778\u201388. https:\/\/doi.org\/10.4103\/IJO.IJO_2414_23","DOI":"10.4103\/IJO.IJO_2414_23"},{"key":"3260_CR22","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.oret.2022.11.003","volume":"7","author":"BA King","year":"2023","unstructured":"King BA, Wilson MW, Kaluzny T, Meredith C, Overbey-Canon J, Chiang J, et al. Intravitreal carboplatin as salvage treatment for progressive vitreous disease in retinoblastoma: A phase I clinical trial. Ophthalmol Retina. 2023;7:354\u20139. https:\/\/doi.org\/10.1016\/j.oret.2022.11.003.","journal-title":"Ophthalmol Retina"},{"key":"3260_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s10637-020-01030-0","volume":"39","author":"MB Cancela","year":"2021","unstructured":"Cancela MB, Zugbi S, Winter U, Martinez AL, Sampor C, Sgroi M, et al. A decision process for drug discovery in retinoblastoma. Invest New Drugs. 2021;39:426\u201341. https:\/\/doi.org\/10.1007\/s10637-020-01030-0.","journal-title":"Invest New Drugs"},{"key":"3260_CR24","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0002-9440(10)64653-6","volume":"157","author":"P Ch\u00e9vez-Barrios","year":"2000","unstructured":"Ch\u00e9vez-Barrios P, Hurwitz MY, Louie K, Marcus KT, Holcombe VN, Schafer P, et al. Metastatic and nonmetastatic models of retinoblastoma. Am J Pathol Elsevier. 2000;157:1405\u201312. https:\/\/doi.org\/10.1016\/S0002-9440(10)64653-6.","journal-title":"Am J Pathol Elsevier"},{"key":"3260_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00418-014-1285-z","volume":"143","author":"M Busch","year":"2015","unstructured":"Busch M, Philippeit C, Weise A, D\u00fcnker N. Re-characterization of established human retinoblastoma cell lines. Histochem Cell Biol. 2015;143:325\u201338. https:\/\/doi.org\/10.1007\/s00418-014-1285-z.","journal-title":"Histochem Cell Biol"},{"key":"3260_CR26","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3892\/ijo.2020.5085","volume":"57","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Jiang H, Xia J, Zhang J. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo. Int J Oncol. 2020;57:697\u2013706. https:\/\/doi.org\/10.3892\/ijo.2020.5085.","journal-title":"Int J Oncol"},{"key":"3260_CR27","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.ajpath.2024.05.006","volume":"194","author":"NA Borah","year":"2024","unstructured":"Borah NA, Mittal R, Sucharita S, Rath S, Kaliki S, Patnaik S, et al. Aurora kinase A is overexpressed in human retinoblastoma and correlates with histopathologic High-Risk factors. Am J Pathol. 2024;194:1780\u201398. https:\/\/doi.org\/10.1016\/j.ajpath.2024.05.006.","journal-title":"Am J Pathol"},{"key":"3260_CR28","doi-asserted-by":"publisher","unstructured":"Reinhard J, Wagner N, Kr\u00e4mer MM, Jarocki M, Joachim SC, Dick HB et al Expression changes and impact of the extracellular matrix on Etoposide resistant human retinoblastoma cell lines. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21124322.","DOI":"10.3390\/ijms21124322"},{"key":"3260_CR29","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.923817","author":"M Kong","year":"2020","unstructured":"Kong M, Han Y, Zhao Y, Zhang H. miR-512-3p overcomes resistance to cisplatin in retinoblastoma by promoting apoptosis induced by Endoplasmic reticulum stress. Med Sci Monit [Internet]. 2020. https:\/\/doi.org\/10.12659\/MSM.923817. [cited 2025 Apr 17];26.","journal-title":"Med Sci Monit [Internet]"},{"key":"3260_CR30","doi-asserted-by":"publisher","unstructured":"Winter U, Aschero R, Fuentes F, Buontempo F, Zugbi S, Sgroi M et al Tridimensional retinoblastoma cultures as vitreous seeds models for Live-Cell imaging of chemotherapy penetration. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20051077","DOI":"10.3390\/ijms20051077"},{"key":"3260_CR31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/term.198","volume":"3","author":"TL Hebert","year":"2009","unstructured":"Hebert TL, Wu X, Yu G, Goh BC, Halvorsen Y-DC, Wang Z, et al. Culture effects of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) on cryopreserved human adipose-derived stromal\/stem cell proliferation and adipogenesis. J Tissue Eng Regen Med. 2009;3:553\u201361. https:\/\/doi.org\/10.1002\/term.198.","journal-title":"J Tissue Eng Regen Med"},{"key":"3260_CR32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13287-020-01589-8","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, Yu H, Yuan Y, Yu JS, Lou Z, Xue Y, et al. The necessity for standardization of glioma stem cell culture: a systematic review. Stem Cell Res Ther. 2020;11:84. https:\/\/doi.org\/10.1186\/s13287-020-01589-8.","journal-title":"Stem Cell Res Ther"},{"key":"3260_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1167\/iovs.64.15.27","volume":"64","author":"S Zugbi","year":"2023","unstructured":"Zugbi S, Aschero R, Ganiewich D, Cancela MB, Winter U, Ottaviani D, et al. Establishment and comprehensive characterization of a novel preclinical platform of metastatic retinoblastoma for therapeutic developments. Invest Ophthalmol Vis Sci. 2023;64:27. https:\/\/doi.org\/10.1167\/iovs.64.15.27.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3260_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-3-642-19022-3_7","volume":"161","author":"F Di Nicolantonio","year":"2003","unstructured":"Di Nicolantonio F, Neale M, Onadim Z, Hungerford JL, Kingston JL, Cree IA. The chemosensitivity profile of retinoblastoma. Recent Results Cancer Res Fortschr Krebsforsch Progres Dans Rech Sur Cancer. 2003;161:73\u201380. https:\/\/doi.org\/10.1007\/978-3-642-19022-3_7.","journal-title":"Recent Results Cancer Res Fortschr Krebsforsch Progres Dans Rech Sur Cancer"},{"key":"3260_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/02656730110087068","volume":"18","author":"M Inomata","year":"2002","unstructured":"Inomata M, Kaneko A, Kunimoto T, Saijo N. In vitro thermo- and thermochemo-sensitivity of retinoblastoma cells from surgical specimens. Int J Hyperth Taylor Francis. 2002;18:50\u201361. https:\/\/doi.org\/10.1080\/02656730110087068.","journal-title":"Int J Hyperth Taylor Francis"},{"key":"3260_CR36","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1002\/1097-0142(20011201)92:11<2933::AID-CNCR10071>3.0.CO;2-G","volume":"92","author":"AY Schouten-van Meeteren","year":"2001","unstructured":"Schouten-van Meeteren AY, van der Valk P, van der Linden HC, Moll AC, Imhof SM, Huismans DR, et al. Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay. Cancer. 2001;92:2933\u201340.","journal-title":"Cancer"},{"key":"3260_CR37","first-page":"3277","volume":"65","author":"S Nagarajan","year":"2024","unstructured":"Nagarajan S, Gowri Priya C, Kim U, Dharmalingam K, Vanniarajan A. Inhibition of KIF14 suppress the retinoblastoma tumor progression with favourable outcome. Invest Ophthalmol Vis Sci. 2024;65:3277\u20133277.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3260_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13046-023-02608-1","volume":"42","author":"A Srimongkol","year":"2023","unstructured":"Srimongkol A, Laosillapacharoen N, Saengwimol D, Chaitankar V, Rojanaporn D, Thanomchard T, et al. Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids. J Exp Clin Cancer Res. 2023;42:39. https:\/\/doi.org\/10.1186\/s13046-023-02608-1.","journal-title":"J Exp Clin Cancer Res"},{"key":"3260_CR39","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.3390\/cancers14235814","volume":"14","author":"N Maricic","year":"2022","unstructured":"Maricic N, Schwermer M, Schramm A, Morosan-Puopolo G, Ketteler P, Brand-Saberi B. Zebrafish as an orthotopic tumor model for retinoblastoma mimicking routes of human metastasis. Cancers. 2022;14:5814. https:\/\/doi.org\/10.3390\/cancers14235814.","journal-title":"Cancers"},{"key":"3260_CR40","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1039\/D4LC00823E","volume":"25","author":"T Gensheimer","year":"2025","unstructured":"Gensheimer T, Veerman D, Van Oosten EM, Segerink L, Garanto A, Van Der Meer AD. Retina-on-chip: engineering functional in vitro models of the human retina using organ-on-chip technology. Lab Chip. 2025;25:996\u20131014. https:\/\/doi.org\/10.1039\/D4LC00823E.","journal-title":"Lab Chip"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03260-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03260-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03260-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:06:57Z","timestamp":1776344817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03260-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3260"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03260-3","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This work was approved by Institutional Ethics Committee (IRB2017009BAS) and followed the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval"}},{"value":"All samples were collected with the informed consent from patient\u2019s parents\/legally authorized persons.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"171"}}